Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1194250
Author(s) Bhattacharyya, Sagnik; Morrison, Paul D.; Fusar-Poli, Paolo; Martin-Santos, Rocio; Borgwardt, Stefan; Winton-Brown, Toby; Nosarti, Chiara; O' Carroll, Colin M.; Seal, Marc; Allen, Paul; Mehta, Mitul A.; Stone, James M.; Tunstall, Nigel; Giampietro, Vincent; Kapur, Shitij; Murray, Robin M.; Zuardi, Antonio W.; Crippa, José A.; Atakan, Zerrin; McGuire, Philip K.
Author(s) at UniBasel Borgwardt, Stefan
Year 2010
Title Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
Journal Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Volume 35
Number 3
Pages / Article-Number 764-74
Mesh terms Acoustic Stimulation, methods; Adult; Brain, physiology; Cannabidiol, pharmacology; Double-Blind Method; Dronabinol, pharmacology; Female; Humans; Magnetic Resonance Imaging, methods; Male; Mental Disorders, prevention & control; Photic Stimulation, methods; Psychomotor Performance, physiology; Young Adult
Abstract Delta-9-tetrahydrocannabinol (Delta-9-THC) and Cannabidiol (CBD), the two main ingredients of the Cannabis sativa plant have distinct symptomatic and behavioral effects. We used functional magnetic resonance imaging (fMRI) in healthy volunteers to examine whether Delta-9-THC and CBD had opposite effects on regional brain function. We then assessed whether pretreatment with CBD can prevent the acute psychotic symptoms induced by Delta-9-THC. Fifteen healthy men with minimal earlier exposure to cannabis were scanned while performing a verbal memory task, a response inhibition task, a sensory processing task, and when viewing fearful faces. Subjects were scanned on three occasions, each preceded by oral administration of Delta-9-THC, CBD, or placebo. BOLD responses were measured using fMRI. In a second experiment, six healthy volunteers were administered Delta-9-THC intravenously on two occasions, after placebo or CBD pretreatment to examine whether CBD could block the psychotic symptoms induced by Delta-9-THC. Delta-9-THC and CBD had opposite effects on activation relative to placebo in the striatum during verbal recall, in the hippocampus during the response inhibition task, in the amygdala when subjects viewed fearful faces, in the superior temporal cortex when subjects listened to speech, and in the occipital cortex during visual processing. In the second experiment, pretreatment with CBD prevented the acute induction of psychotic symptoms by Delta-9-tetrahydrocannabinol. Delta-9-THC and CBD can have opposite effects on regional brain function, which may underlie their different symptomatic and behavioral effects, and CBD's ability to block the psychotogenic effects of Delta-9-THC.
Publisher Nature Publishing Group
ISSN/ISBN 0893-133X ; 1740-634X
URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055598/
edoc-URL https://edoc.unibas.ch/63222/
Full Text on edoc No
Digital Object Identifier DOI 10.1038/npp.2009.184
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19924114
ISI-Number WOS:000273635100017
Document type (ISI) Journal Article, Randomized Controlled Trial
 
   

MCSS v5.8 PRO. 0.344 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
28/04/2024